Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence

BMC Immunology

Volumn 7, Issue , 2006, Pages

  Tsiakalou, Vagia ^a   Tsangaridou, Elena ^a   Polioudaki, Hara ^a   Nifli, Artemissia Phoebe ^a   Koulentaki, Meri ^a   Akoumianaki, Tonia ^a   Kouroumalis, Elias ^a   Castanas, Elias ^a   Theodoropoulos, Panayiotis A ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; FORMALDEHYDE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOPLASM; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; MALE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; SCREENING TEST;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; CELL LINE, TUMOR; FEMALE; FIXATIVES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FORMALDEHYDE; HELA CELLS; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NUCLEAR ENVELOPE;

EID: 33748993680     PISSN: 14712172     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-7-20     Document Type: Article

References (20)

1. Georgatos SD, Theodoropoulos PA: Rules to remodel by: what drives nuclear envelope disassembly and reassembly during mitosis? Crit Rev Eukaryot Gene Expr 1999, 9(3-4):373-381.
2. Coppo P, Clauvel JP, Bengoufa D, Fuentes V, Gouilleux-Gruart V, Courvalin JC, Lassoued K. Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptides. Am J Hematol 2004, 77 241-249:.
3. Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, Maggioni M, Meroni PL, Penner E, Wesierska-Gadek J: Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001, 34(3):366-372.
4. Miyachi K, Hankins RW, Matsushima H, Kikuchi F, Inomata T, Horigome T, Shibata M, Onozuka Y, Ueno Y, Hashimoto E, Hayashi N, Shibuya A, Amaki S, Miyakawa H: Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun 2003, 20(3):247-254.
5. Senecal JL, Grodzincky RJ, Raynauld JP, IUthman I, Nava A, Guimond M, Raymond Y: Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Arthritie Rheum 2000, 42:1347-1353.
6. Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM: Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 1996, 98(8):1888-1896.
7. Van de Water J, Cooper A, Surh CD, Coppell R, Danner D, Ansari A, Dickson R, Gershwin ME: Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl Med 1989, 320(21):1377-1380.
8. Worman HJ, Courvalin JC: Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2003, 2(4):211-217.
9. Bogdanos DP, Baum H, Vergani D: Antimitochondrial and other autoantibodies. Clin Liver Dis 2003, 7(4):759-77, vi.
10. Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D: Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 2005, 54(4):528-532.
11. Szostecki C, Krippner H, Penner E, Bautz FA: Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol 1987, 68(1):108-116.
12. Sternsdorf T, Guldner HH, Szostecki C, Grotzinger T, Will H: Two nuclear dot-associated proteins, PML and Sp 100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 1995, 42(2):257-268.
13. Wesierska-Gadek J, Hohenuer H, Hitchman E, Penner E: Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 1996, 110(3):840-847.
14. Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW: The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 1990, 86(1):279-285.
15. Lassoued K, Brenard R, Degos F, Courvalin JC, Andre C, Danon F, Brouet JC, Zine-el-Abidine Y, Degott C, Zafrani S, et al.: Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology 1990, 99(1):181-186.
16. Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T: Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC. Mol Biol Rep 1996, 23(3-4):227-234.
17. Georgatos SD, Pyrpasopoulou A, Theodoropoulos PA. Nuclear envelope breakdown in mammalian cells involves stepwise lamina disassembly and microtubule-drive deformation of the nuclear membrane. J Cell Sci 1997, 110 (Pt 17):2129-2140.
18. Dwyer N, Blobel G: A modified procedure for the isolation of a pore complex-lamina fraction from rat liver nuclei. J Cell Biol 1976, 70(3):581-591.
19. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, Fujikawa H, Gershwin ME: Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001, 34(2):243-248.
20. Ou Y, Enarson P, Rattner JB, Barr SG, Fritzler MJ: The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence. Clin Exp Immunol 2004, 136(2):379-387.